• For More Information Call (239) 541-7275

  • Mold solutions

  • DuraBan’s antimicrobial and mold technology is a surface modifying antimicrobial treatment that creates a new surface that is resistant to microbial attack. Unlike all other conventional antimicrobials, our products do not off-gas, leach, diffuse, migrate, volatilize or otherwise leave the surface to which they have been applied. The result is an extraordinary efficacy profile, unmatched by other products.

    Antimicrobials can be divided into two major categories: bound and unbound. These terms refer to whether or not the antimicrobial has the capacity to molecularly bond to the surface on which it is applied.

    An unbound antimicrobial has the greater potential for safety concerns because it must diffuse or leach from the treated surface and be consumed by the microorganism to be effective. Most conventional antimicrobials are intended to act quickly and dissipate quickly to minimize the danger to humans, animals and treated objects. Others use the time release capsule approach and obtain a longer working life by burying the antimicrobial in a paint, glue, binder or other coating and counting on slow migration to the surface. Conventional antimicrobials, even those applied in a carrier, must diffuse (wash off) and create a “zone of inhibition” in order to function properly.

    Once inside the organism, the chemical agent will act like a poison, interrupting some key metabolic or life sustaining process of the cell and causing it to die. Once the antimicrobial is depleted or washed away during regular maintenance, protection vanishes. After application, an unbound antimicrobial continues to diffuse or leach from the treated surface. As this diffusion continues, the target organism builds up a tolerance to those particular antimicrobials. Highly resistant strains can develop which are immune to what was once an effective dose. Just such a phenomenon (genetic adaptation) is of special concern to the health care industry which has observed the development of more potent strains of disease-causing organisms which are highly resistant to conventional antibiotics.